glaxosmithkline plc-spon adr
(GSKN:Mexico)
Executive Profile*
Jean StéphenneChairman of Gsk Biologicals and President of Gsk Biologicals, GlaxoSmithKline plc |
| Age | Total Calculated Compensation | This person is connected to 111 board members in 9 different organizations across 9 different industries. See Board Relationships |
| 63 | -- |
Background*
Mr. Jean Stéphenne, Baron has been the Chairman and President of GSK Biologicals at GlaxoSmithKline plc since March 12, 2010. Mr. Stéphenne served as the General Manager of GSK Biologicals. He served as the Chief Executive Officer and President of GlaxoSmithKline Biologicals S.A., Belgium since 1998 and served as its Chairman. Mr. Stéphenne served as the President of GlaxoSmithKline plc since May 2008. He began his career with SmithKline-Rit, where he moved up the ranks ...
Corporate Headquarters*980 Great West RoadBrentford, Middlesex TW8 9GS United Kingdom Phone: 44 20 8047 5000 Fax: 44 20 8047 7807 Board Members Memberships*Independent Chairman and Chairman of Remuneration & Nominations Committee Chairman, Chief Executive Officer and President Director Director 2000-Present Chairman, Chairman of Compensation Committee, Chairman of Nomination Committee and Member of Audit Committee 2001-Present Independent Non-Executive Director, Member of Governance, Nomination & Remuneration Committee and Member of Audit, Risk & Compliance Committee 2003-Present Director and Member of Nomination & Remuneration Committee 2012-Present Chairman
Education*Bachelor's Degree Universite catholique de Louvain
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*There is no Total Compensation data available. |
| Recently Viewed | |||
| GSKN:MM | $673.10 MXN | -3.15 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Marijn E. Dekkers Ph.D. | Chairman of Management Board and Chief Executive Officer Bayer AG | €3.0M |
| Kenneth C. Frazier | Chairman, Chief Executive Officer and President Merck & Co. Inc. | $1.5M |
| Inge G. Thulin | Chairman, Chief Executive Officer and President 3M Company | $1.2M |
| Christopher A. Viehbacher | Chief Executive Officer, Director and Member of Strategy Committee Sanofi | €3.5M |
| Severin Schwan | Chief Executive Officer and Director Roche Holding AG | SFr.6.5M | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Chicago, IL | DunnhumbyusaPosted: Jun 18
- Thomasville, GA | Flowers FoodsPosted: Jun 07
- San Francisco, CA | YelpPosted: Jun 06
- San Francisco, CA | PeoplematterPosted: Jun 06
Sponsored Financial Commentaries
Sponsored Links
To contact GLAXOSMITHKLINE PLC-SPON ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
